BNIKF Recent News Benitec Biopharma Announces Pri
Post# of 5
Posted On: 03/03/2014 2:37:12 AM
BNIKF Recent News
Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants PR Newswire - Mon Feb 24, 6:30AM CST
Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr. David Suhy to Regen BioPharma Inc.'s Scientific Advisor Board Marketwire - Tue Sep 17, 9:06AM CDT
Regen BioPharma Inc licenses cancer gene silencing technology, expanding its cancer vaccine patent portfolio M2 - Fri Aug 09, 4:39AM CDT
Regen BioPharma Inc. Licenses Cancer Gene Silencing Technology From Benitec BioPharma Marketwire - Thu Aug 08, 8:48AM CDT
HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC) PR Newswire - Tue Apr 16, 5:30PM CDT
Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections PR Newswire - Mon Apr 15, 7:00PM CDT
Appointment of Mr. Kevin Buchi to Benitec Board PR Newswire - Wed Apr 10, 9:23PM CDT
Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial PR Newswire - Thu Mar 21, 6:00PM CDT
Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants PR Newswire - Mon Feb 24, 6:30AM CST
Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr. David Suhy to Regen BioPharma Inc.'s Scientific Advisor Board Marketwire - Tue Sep 17, 9:06AM CDT
Regen BioPharma Inc licenses cancer gene silencing technology, expanding its cancer vaccine patent portfolio M2 - Fri Aug 09, 4:39AM CDT
Regen BioPharma Inc. Licenses Cancer Gene Silencing Technology From Benitec BioPharma Marketwire - Thu Aug 08, 8:48AM CDT
HCV clinical trial application submitted to Recombinant DNA Advisory Committee (RAC) PR Newswire - Tue Apr 16, 5:30PM CDT
Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections PR Newswire - Mon Apr 15, 7:00PM CDT
Appointment of Mr. Kevin Buchi to Benitec Board PR Newswire - Wed Apr 10, 9:23PM CDT
Benitec Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial PR Newswire - Thu Mar 21, 6:00PM CDT
(0)
(0)